Media coverage
2
Media coverage
Title Caribou Biosciences Announces FDA Clearance Of IND Application For CB-011, An Allogeneic Anti-BCMA CAR-T Cell Therapy For The Treatment Of Relapsed Or Refractory Multiple Myeloma Media name/outlet Drug Discovery Online Country/Territory United States Date 22/11/22 URL ct.moreover.com/?a=49320224842&p=1gw&v=1&x=G64zgEHi_NBnMlaEKQkMrA Persons Sundar Jagannath Title Caribou Biosciences Announces FDA Clearance Of IND Application For CB-011, An Allogeneic Anti-BCMA CAR-T Cell Therapy For The Treatment Of Relapsed Or Refractory Multiple Myeloma Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 21/11/22 URL ct.moreover.com/?a=49311799275&p=1gw&v=1&x=Lpey0uHD1hE5fa9mJ1Sswg Persons Sundar Jagannath